Clinical Trial to Assess the Influence of Gestational Stage and Maternal Age on Arterial Stiffness of the Mother

This study has been terminated.
(recruitment failure)
Information provided by:
Technische Universität Dresden Identifier:
First received: September 14, 2005
Last updated: February 12, 2009
Last verified: September 2005
This is a single-centre, open, parallel-group study with three age groups; no study medication or intervention will be provided. This is a longitudinal follow-up of physiological parameters.

Condition Phase
Pregnancy Trimester, First
Pregnancy Trimester, Second
Pregnancy Trimester, Third
Phase 1

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: An Open Clinical Trial to Assess the Influence of Gestational Stage and Maternal Age on Arterial Stiffness of the Mother (Hormonal and Age Related Changes of the Aortal Elasticity)

Further study details as provided by Technische Universität Dresden:

Enrollment: 0
Study Start Date: January 2006
Study Completion Date: June 2006
20 to 22 years
30 to 32 years
40 to 42 years

Detailed Description:
The subjects will be investigated as outpatients. For each subject, 4 individual dates with a duration of approximately 30 minutes each are scheduled - at the end of the first trimenon, at the end of the second trimenon, 4 weeks prior to the calculated date of birth, and 6 weeks after the effective date of birth.

Ages Eligible for Study:   20 Years to 42 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
three age groups

Inclusion Criteria:

  • Pregnant women without major concomitant disease
  • Willing and able to provide informed consent
  • Age (three age groups):

    • 20 to 22 years
    • 30 to 32 years
    • 40 to 42 years

Exclusion Criteria:

  • Non pregnant women
  • Men
  • No informed consent
  • Age not included in inclusion criteria
  • Major concomitant disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00180219

Medizinische Fakultät der Technischen Universität Dresden
Dresden, Germany, 01307
Sponsors and Collaborators
Technische Universität Dresden
Principal Investigator: Joachim Siegert, MD, DPharm, Phd Technische Universität Dresden
  More Information

No publications provided Identifier: NCT00180219     History of Changes
Other Study ID Numbers: IKPD-S-01-04
Study First Received: September 14, 2005
Last Updated: February 12, 2009
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

Keywords provided by Technische Universität Dresden:
G08.520.769.550.520 processed this record on December 01, 2015